Guy Kantor Selected Research

hafnium oxide

1/2019	NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial.
2/2017	First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guy Kantor Research Topics

Disease

8	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 12/2002
6	Neoplasms (Cancer) 01/2024 - 11/2004
3	Astrocytoma (Pilocytic Astrocytoma) 11/2016 - 04/2007
2	Retroperitoneal liposarcoma 01/2023 - 12/2012
2	Glioma (Gliomas) 11/2016 - 11/2016
2	Oligodendroglioma 11/2016 - 11/2016
1	Liposarcoma 01/2023
1	Pathologic Complete Response 11/2022
1	Osteosarcoma (Osteogenic Sarcoma) 09/2022
1	Hypotension (Low Blood Pressure) 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Pain (Aches) 01/2019
1	Chordoma 01/2017
1	Virus Diseases (Viral Diseases) 11/2016
1	Infections 11/2016
1	Chronic Hepatitis B 11/2016
1	HIV Infections (HIV Infection) 11/2016
1	Fatigue 11/2016
1	Desmoplastic Small Round Cell Tumor 01/2016
1	Neoplasm Metastasis (Metastasis) 02/2014
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2009
1	Glioblastoma (Glioblastoma Multiforme) 04/2007
1	Lung Neoplasms (Lung Cancer) 07/2005

Drug/Important Bio-Agent (IBA)

2	hafnium oxideIBA 01/2019 - 02/2017
2	Temozolomide (Temodar)FDA LinkGeneric 11/2016 - 11/2016
1	CalciumIBA 01/2024
1	MetalsIBA 01/2024
1	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 01/2024
1	OxidesIBA 01/2024
1	Proteins (Proteins, Gene)FDA Link 09/2022
1	Methyl MethanesulfonateIBA 09/2022
1	Aligeron (AS 2)IBA 07/2005

Therapy/Procedure

16	Radiotherapy 01/2024 - 12/2002
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2023 - 12/2012
3	Drug Therapy (Chemotherapy) 11/2016 - 05/2010
1	Proton Therapy 01/2017
1	Therapeutics 01/2017
1	Oral Administration 11/2016
1	Combined Modality Therapy 01/2016
1	Brachytherapy 01/2006
1	Conservative Treatment 11/2004
1	Surgical Amputation (Amputations) 11/2004